Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Spot and Futures Linkage Sparks Controversy, VELVET Token Faces Significant Selling Pressure Following Short-Term Surge

Spot and Futures Linkage Sparks Controversy, VELVET Token Faces Significant Selling Pressure Following Short-Term Surge

BlockBeatsBlockBeats2026/06/11 01:07

BlockBeats News, June 11, according to EmberCN monitoring, the DEX project Velvet Capital's token VELVET recently experienced abnormal price fluctuations, soaring from around $0.09 to $0.9 in a short period of time, with a cumulative increase of 10x.


During the rapid price increase, the project's associated address transferred approximately 22 million VELVET to Bitget and an exchange within the past 3 days, totaling about $19.8 million, interpreted by the market as potential concentrated selling pressure.


In addition, the liquidity provider DWF Labs also moved around 6.68 million VELVET to the aforementioned exchanges in the past month, worth approximately $6 million.


The on-chain fund flow coincided with the rapid price surge, sparking community discussion on the "spot price ramp-up + contract harvesting" model.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.

Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.

智通财经•2026/09/29 03:11

Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request

A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.

智通财经•2026/09/29 02:46

After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.

Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.

智通财经•2026/09/29 02:46